Skip Navigation LinksHome | Editors' Blog
A story in today’s Part B News looks at the outrageous provider kickbacks uncovered in the current trial of several Insys Therapeutics executives, and how you can make sure nothing like that happens where you work. In this blog post, three of our contributors have further thought on the matter.
Details of an EHR vendor's settlement may leave you feeling like it's Groundhog Day.
Improper claims for specimen validity testing may be the latest compliance risk associated with urine drug tests.
The Food and Drug Administration (FDA) has announced a Class 1 recall of certain Swan-Ganz Thermodilution Catheters manufactured by Edwards Lifesciences in Irvine, Calif.


User Name:
Welcome to the new Part B News Online. If you are a returning user having trouble logging in, please click here.
Back to top